People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Biotech / Pharma, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ClearLight Biotechnologies, LLC | — | Biotech / Pharma | Seed | $8.8M | $113.9M | 2018 |
| Island Pharmaceuticals Ltd | — | Biotechnology | Seed | $1.2M | $7.1M | 2024 |
| Nuro Pharma Inc | — | Pharmaceuticals | Pre-Seed | $658K | $31.1M | 2012 |
Albert Hansen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Albert Hansen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Fares | 1 | 3 |
| David Foster | 1 | 3 |
| John Snyder | 1 | 2 |
| David Brookes | 1 | 1 |
| Paul MacLeman | 1 | 1 |
| Karl Deisseroth | 1 | 1 |
| Sarah McCurdy | 1 | 1 |
| Laurie Goodman | 1 | 1 |
| Alex Wiegers | 1 | 1 |
| Nick McCoy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.